Aker Christopher Ray
Insider CIK 1762611 · RGLS Sr. VP & General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 487,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 363,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 70,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 393,750 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 45,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 7,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 48,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 21,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 33,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 750 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 2,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | U Tender | 2025-06-25 | 2025-06-27 | 60,796 | — | $0 | 83,125 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer | 2025-06-25 | 2025-06-27 | 83,125 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2025-01-30 | 2025-01-31 | 487,500 | — | $0 | 487,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2025-01-14 | 2025-01-15 | 5,088 | $1.26 | $6.4K | 49,546 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2025-01-13 | 2025-01-15 | 38,547 | $1.26 | $48.6K | 54,634 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-01-09 | 2025-01-10 | 17,500 | $1.30 | $22.8K | 93,181 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-01-09 | 2025-01-10 | 66,625 | $1.36 | $90.6K | 75,681 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-20 | 2024-05-21 | 363,000 | — | $0 | 363,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2024-01-18 | 2024-01-18 | 5,468 | $1.19 | $6.5K | 10,056 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-01-12 | 2024-01-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2024-01-12 | 2024-01-17 | 11,250 | — | $0 | 15,524 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-08-10 | 2023-08-14 | 393,750 | — | $0 | 393,750 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-01-11 | 2023-01-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-01-11 | 2023-01-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-05-09 | 2022-05-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-01-12 | 2022-01-26 | 480,000 | — | $0 | 480,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2021-05-17 | 2021-05-17 | 860 | $0.89 | $765 | 41,754 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2021-02-16 | 2021-02-17 | 828 | $1.72 | $1.4K | 42,614 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 180,000 | — | $0 | 180,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-11-16 | 2020-11-18 | 876 | $0.52 | $456 | 25,762 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-08-14 | 2020-08-17 | 872 | $0.61 | $532 | 26,638 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-05-15 | 2020-05-18 | 909 | $0.63 | $573 | 27,510 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-02-18 | 2020-02-19 | 888 | $0.83 | $737 | 28,419 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-01-22 | 2020-01-24 | 210,000 | — | $0 | 210,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2020-01-02 | 2020-01-03 | 2,239 | $0.97 | $2.2K | 29,307 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-11-14 | 2019-11-15 | 833 | $0.64 | $533 | 31,546 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 335,000 | — | $0 | 335,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-10-01 | 2019-10-02 | 2,346 | $0.68 | $1.6K | 32,379 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-08-15 | 2019-08-16 | 899 | $0.55 | $494 | 34,725 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-07-01 | 2019-07-02 | 2,225 | $1.31 | $2.9K | 35,624 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-05-15 | 2019-05-16 | 6,950 | $1.41 | $9.8K | 59,309 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-05-14 | 2019-05-16 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-05-14 | 2019-05-16 | 38,512 | — | $0 | 66,259 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-04-01 | 2019-04-03 | 2,710 | $0.98 | $2.7K | 6,287 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-02-05 | 2019-02-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-02-05 | 2019-02-06 | 25,000 | — | $0 | 27,747 | SEC↗ |